Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening

Cancer

Volumn 123, Issue 2, 2017, Pages 312-318

  Whitley, Elizabeth M ^a   Raich, Peter C ^b,c   Dudley, Donald J ^d,e   Freund, Karen M ^f   Paskett, Electra D ^g,h   Patierno, Steven R ^i,j   Simon, Melissa ^k   Warren Mears, Victoria ^l   Snyder, Frederick R ^m  

^a Air Pollution Control Division   (United States)

^b DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d University of Texas Health Science Center at San Antonio   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ WASHINGTON CANCER INSTITUTE   (United States)

^j DUKE CANCER INSTITUTE   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l Northwest Tribal Epidemiology Center   (United States)

^m NOVA Research Company   (United States)

more..

Author keywords

cancer screening; comorbidity; patient navigation

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER SCREENING; CHARLSON COMORBIDITY INDEX; CLINICAL EFFECTIVENESS; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; TIME; UTERINE CERVIX CANCER; EARLY CANCER DIAGNOSIS; HEALTH CARE DISPARITY; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; COMORBIDITY; EARLY DETECTION OF CANCER; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT NAVIGATION; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 84992490656     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30316     Document Type: Article

References (27)

1. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer. 1996;77:834–842.
2. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;7:285:885–892.
3. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of comorbidity on life expectancy among men with localized prostate cancer. J Urol. 1996;1:127–132.
4. Yancik R, Wesley MN, Ries LA, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82:2123–2134.
5. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004;22:3099–3103.
6. Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocols and measures. Cancer. 2008;113:3391–3399.
7. Freund KM, Battaglia TA, Calhoun E, et al. The impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst. 2014;106:dju15.
8. Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev. 2012;21:1629–1638.
9. Battaglia TA, Bak SM, Heeren T, et al. Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal screening. Cancer Epidemiol Biomarkers Prev. 2012;21:1645–1654.
10. Fiscella K, Whitley E, Hendren S, et al. Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2012;21:1673–1681.
11. Dudley DJ, Drake J, Quinlan J, et al. Beneficial effects of a combined navigator/promatora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev. 2012;21:639–1644.
12. Wells KJ, Lee JH, Clacano ER, et al. A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev. 2012;21:1664–1672.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
14. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682.
15. Katz M, Young GS, Reiter PL, et al. Barriers reported among patients with breast and cervical abnormalities in the Patient Navigation Research Program: impact on timely care. Womens Health Issues. 2014;24:e155–e162.
16. Ramachandran A, Freund KM, Bak SM, et al. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation. J Womens Health. 2015;24:30–36.
17. Calhoun EA, Whitley EM, Esparza A, et al. A national patient navigator training program. Health Promot Pract. 2010;11:205–215.
18. Singh B, Singh A, Ahmed A, et al. Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records. Mayo Clin Proc. 2012;87:817–824.
19. Clinical Research Services, NOVA Research Company. Bethesda, Maryland.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
21. Teppo H, Alho OP. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol. 2009;45:692–695.
22. King CJ, Chen J, Dagher RK, Holt CL, Thomas SB. Decomposing differences in medical care access among cancer survivors by race and ethnicity. Am J Med Qual. 2015;30:459–469.
23. Lott JP, Narayan D, Soulos PR, Aminawung J, Gross CP. Delay of surgery for melanoma among Medicare beneficiaries. JAMA Dermatol. 2015;151:731–741.
24. Hong CS, Atlas SJ, Ashburner JM, et al. Evaluating a model to predict primary care physician–defined complexity in a large academic primary care practice-based research network. J Gen Intern Med. 2015;30:1741–1747.
25. Samson P, Patel A, Garrett T, et al. Effects of delayed surgical resection on short-term and long-term outcomes in clinical stage 1 non–small cell lung cancer. Ann Thorac Surg. 2015;99:1906–1912.
26. Roetzheim RG, Freund KM, Corle DK, et al. Analysis of combined data from heterogeneous study designs: an applied example from the Patient Navigation Research Program. Clin Trials. 2012;9:176–187.
27. Commission on Cancer. Cancer Program Standards: Ensuring Patient-Centered Care. Chicago, IL: American College of Surgeons; 2015.